Your browser doesn't support javascript.
loading
Switching From Originator to Biosimilar Infliximab in Paediatric Inflammatory Bowel Disease Is Feasible and Uneventful.
Gervais, Lisa; McLean, Luke L; Wilson, Michelle L; Cameron, Carol; Curtis, Lee; Garrick, Vikki; Armstrong, Kat; Tayler, Rachel; Henderson, Paul; Hansen, Richard; Chalmers, Iain; Wilson, David C; Russell, Richard K.
Afiliación
  • Gervais L; Department of Paediatric Gastroenterology, Royal Hospital for Children, Glasgow.
  • McLean LL; Department of Paediatric Gastroenterology, Royal Hospital for Children, Glasgow.
  • Wilson ML; Department of Paediatric Gastroenterology, Royal Hospital for Sick Children, Edinburgh.
  • Cameron C; Department of Paediatric Gastroenterology, Royal Aberdeen Children's Hospital, Aberdeen, UK.
  • Curtis L; Department of Paediatric Gastroenterology, Royal Hospital for Children, Glasgow.
  • Garrick V; Department of Paediatric Gastroenterology, Royal Hospital for Children, Glasgow.
  • Armstrong K; Department of Paediatric Gastroenterology, Royal Hospital for Sick Children, Edinburgh.
  • Tayler R; Department of Paediatric Gastroenterology, Royal Hospital for Children, Glasgow.
  • Henderson P; Department of Paediatric Gastroenterology, Royal Hospital for Sick Children, Edinburgh.
  • Hansen R; Department of Paediatric Gastroenterology, Royal Hospital for Children, Glasgow.
  • Chalmers I; Department of Paediatric Gastroenterology, Royal Aberdeen Children's Hospital, Aberdeen, UK.
  • Wilson DC; Department of Paediatric Gastroenterology, Royal Hospital for Sick Children, Edinburgh.
  • Russell RK; Department of Paediatric Gastroenterology, Royal Hospital for Children, Glasgow.
J Pediatr Gastroenterol Nutr ; 67(6): 745-748, 2018 12.
Article en En | MEDLINE | ID: mdl-29985877
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Fármacos Gastrointestinales / Colitis Ulcerosa / Enfermedad de Crohn / Sustitución de Medicamentos / Biosimilares Farmacéuticos / Infliximab Tipo de estudio: Evaluation_studies / Observational_studies Límite: Adolescent / Child / Female / Humans / Male Idioma: En Revista: J Pediatr Gastroenterol Nutr Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Fármacos Gastrointestinales / Colitis Ulcerosa / Enfermedad de Crohn / Sustitución de Medicamentos / Biosimilares Farmacéuticos / Infliximab Tipo de estudio: Evaluation_studies / Observational_studies Límite: Adolescent / Child / Female / Humans / Male Idioma: En Revista: J Pediatr Gastroenterol Nutr Año: 2018 Tipo del documento: Article